Chiesi USA
NC - CaryBiotechnology
Focus: Chiesi USA is the North American subsidiary of a European specialty pharma company focused on small molecules, biologics, and orphan drugs across rare diseases and niche therapeutic areas. The company operates from Cary, NC with a concentrated portfolio in respiratory, neonatal, and rare disease indications.
Profile data last refreshed 4d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Chiesi USA
AI assessmentNot HiringNo open roles listed right now. Follow Chiesi USA to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
12 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Poractant Alfa
Stable
Peak
Phase 4 commercial product addressing critical neonatal respiratory condition, core to company's neonatal franchise.
Mannitol Inhalant Product
Help build intelligence for Chiesi USA
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.